Shareholders Have Faith in Loss-making Madrigal Pharmaceuticals (NASDAQ:MDGL) as Stock Climbs 55% in Past Week, Taking Three-year Gain to 267%

Simply Wall St03:40

Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences

GlobeNewswireNov 6 21:00

Madrigal Pharmaceuticals Insider Sold Shares Worth $1,504,703, According to a Recent SEC Filing

MT NewswiresNov 6 16:28

Madrigal Pharmaceuticals Is Maintained at Neutral by B. Riley Securities

Dow JonesNov 6 00:22 · Ratings

Analysts Offer Insights on Healthcare Companies: Madrigal Pharmaceuticals (MDGL), Travere Therapeutics (TVTX) and Regeneron (REGN)

TipRanksNov 5 14:11 · Ratings

Express News | Madrigal Pharmaceuticals Inc : B. Riley Raises Target Price to $236 From $194

BreakingsNov 5 12:31